Literature DB >> 16542858

Lack of association between C3435T nucleotide MDR1 genetic polymorphism and multidrug-resistant epilepsy.

Dong Wook Kim1, Manho Kim, Sang Kun Lee, Rami Kang, Seo-Young Lee.   

Abstract

The variability of P-glycoprotein expression in individuals is linked to a C3435T polymorphism of the multidrug-resistance 1 (MDR1) gene, and the CC genotype at the C3435T polymorphism was reported to be associated with multidrug resistance in epilepsy patients. Since population frequencies of polymorphic genes depend on ethnic specificity, we investigated functional significance of the C3435T polymorphism of the MDR1 gene in Korean epilepsy patients. One hundred and eight patients with drug-responsive epilepsy, 63 patients with drug-resistant epilepsy, and 219 control migraine subjects were studied, but the analysis for C3435T allele showed no significant association between the CC genotype and the multidrug-resistant epilepsy. We suggest that influence of the C3435T polymorphism in the multidrug-resistant epilepsy may not be significant in Korean populations and further investigations in various ethnic populations would be necessary to clarify the effect of C3435T polymorphism on the mutidrug resistance in epilepsy patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16542858     DOI: 10.1016/j.seizure.2006.02.015

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  13 in total

1.  Biomarkers for antiepileptic drug response.

Authors:  Tracy A Glauser
Journal:  Biomark Med       Date:  2011-10       Impact factor: 2.851

2.  Variability in expression of the human MDR1 drug efflux transporter and genetic variation of the ABCB1 gene: implications for drug-resistant epilepsy.

Authors:  Anna Heinrich; Xiao-Bo Zhong; Theodore P Rasmussen
Journal:  Curr Opin Toxicol       Date:  2018-12-18

3.  Association of MDR1 gene C3435T polymorphism with childhood intractable epilepsy: a meta-analysis.

Authors:  Guilian Sun; Xue Sun; Limei Guan
Journal:  J Neural Transm (Vienna)       Date:  2014-02-20       Impact factor: 3.575

4.  Role of multidrug transporters in neurotherapeutics.

Authors:  Manna Jose; Sanjeev V Thomas
Journal:  Ann Indian Acad Neurol       Date:  2009-04       Impact factor: 1.383

Review 5.  Pharmacogenetics of chronic pain and its treatment.

Authors:  Svatopluk Světlík; Karolína Hronová; Hana Bakhouche; Olga Matoušková; Ondřej Slanař
Journal:  Mediators Inflamm       Date:  2013-05-20       Impact factor: 4.711

6.  Drug resistance in epilepsy and the ABCB1 gene: The clinical perspective.

Authors:  Abhijit Das; Shabeesh Balan; Moinak Banerjee; Kurupath Radhakrishnan
Journal:  Indian J Hum Genet       Date:  2011-05

Review 7.  The ABCB1, ABCC2 and RALBP1 polymorphisms are associated with carbamazepine response in epileptic patient: a systematic review.

Authors:  Wefa Boughrara; Amina Chentouf
Journal:  Acta Neurol Belg       Date:  2022-03-24       Impact factor: 2.471

8.  The roles of variants in human multidrug resistance (MDR1) gene and their haplotypes on antiepileptic drugs response: a meta-analysis of 57 studies.

Authors:  Hui Li; Bing Wang; Cheng Chang; Minghua Wu; Yun Xu; Yajun Jiang
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

9.  Genetic association analysis of ATP binding cassette protein family reveals a novel association of ABCB1 genetic variants with epilepsy risk, but not with drug-resistance.

Authors:  Shabeesh Balan; Sumitha Prameela Bharathan; Neetha Nanoth Vellichiramal; Sanish Sathyan; Vijai Joseph; Kurupath Radhakrishnan; Moinak Banerjee
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

10.  The drug-transporter gene MDR1 C3435T and G2677T/A polymorphisms and the risk of multidrug-resistant epilepsy in Turkish children.

Authors:  Mehmet Seven; Bahadir Batar; Selin Unal; Gozde Yesil; Adnan Yuksel; Mehmet Guven
Journal:  Mol Biol Rep       Date:  2013-11-10       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.